The Protective Action of Nitrone-Based Free Radical Traps in Neurodegenerative Diseases

  • Robert A. Floyd
Part of the GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia book series (GWUN)


Nitrone-based free radical traps (NRTs) have been shown to protect in several experimental animal models of neurodegenerative diseases and to mitigate other parameters associated with the aging process in brain. Since the prototype NRTs were first utilized in analytical chemistry to trap and characterize the presence of free radicals in chemical and biochemical systems, it is the simplest hypothesis that they protect by trapping crucial free radicals involved in the oxidative damage that occurs in animal models of neurodegenerative diseases. This remains to be rigorously proven. Pertinent data supporting this concept are presented in a framework of the knowledge accrued from studies on oxidative damage in brain.


Electron Spin Resonance Middle Cerebral Artery Occlusion Multiple System Atrophy Infarct Volume Cerebellar Granule Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.M. McCord and I. Fridovich, Superoxide dismutase: An enzymic function for erythrocuperin (hemocuprein), J Biol Chem. 244(22):6049 (1969).PubMedGoogle Scholar
  2. 2.
    R. A. Floyd, Role of oxygen free radicals in carcinogenesis and brain ischemia, FASEB J. 4:2587 (1990).PubMedGoogle Scholar
  3. 3.
    R.A. Floyd and J.M. Carney, Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress, Ann. Neurol. 32:S22 (1992).PubMedCrossRefGoogle Scholar
  4. 4.
    J.T. Coyle and P. Puttfarcken, Oxidative stress, glutamate, and neurodegenerative disorders, Science 262:689 (1993).PubMedCrossRefGoogle Scholar
  5. 5.
    E.D. Hall and J.M. Braughler, Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation, Free Radic. Biol. Med. 6:303 (1989).PubMedCrossRefGoogle Scholar
  6. 6.
    M.M. Zaleska and R.A. Floyd, Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron, Neurochem. Res. 10:397 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    M.M. Zaleska, K. Nagy, and R.A. Floyd, Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes, Neuropathol. 14:597 (1989).Google Scholar
  8. 8.
    R.A. Floyd, J.J. Watson, R.K. Wong, D.H. Altmiller, and R.C. Rickard, Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanisms of formation, Free Radic. Res. Commun. 1:163 (1986).PubMedCrossRefGoogle Scholar
  9. 9.
    R.A. Floyd, M.S. West, K.L. Eneff, J.E. Schneider, P.K. Wong, D.T. Tingey, and W.E. Hogsett, Conditions influencing yield and analysis of 8-hydroxy-2′-deoxyguanosine in oxidatively damaged DNA, Anal. Biochem. 188:155 (1990).PubMedCrossRefGoogle Scholar
  10. 10.
    E.G. Janzen, Spin trapping, Ace. Chem. Res. 4:31 (1971).CrossRefGoogle Scholar
  11. 11.
    W. Cao, J.M. Carney, A. Duchon, R.A. Floyd, and M. Chevion, Oxygen free radical involvement in ischemia and reperfusion injury to brain, Neurosci. Lett. 88:233 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    J.M. Carney, T. Tatsuno, and R.A. Floyd, The role of oxygen radicals in ischemic brain damage: Free radical production, protein oxidation and tissue dysfunction, in: “Pharmacology of Cerebral Ischemia,” J. Krieglstein and H. Oberpichler-Schwenk, eds., Publisher Wissenschaftliche Verlagsgesellschaft, Stuttgart (1992).Google Scholar
  13. 13.
    C.N. Oliver, P.E. Starke-Reed, E.R. Stadtman, G.J. Liu, J.M. Carney, and R.A. Floyd, Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischernia/reperfusion-induced injury to gerbil brain, Proc. Natl. Acad. Sci. USA 87:5144 (1990).PubMedCrossRefGoogle Scholar
  14. 14.
    G. Delbarre, B. Delbarre, F. Calinon, C. Loiret, and A. Ferger, Accumulation of glutamate, asparate and GABA in the hippocampus of gerbil after transient cerebral ischemia, Soc. Neurosci. Abst. 15:1174 (1989).Google Scholar
  15. 15.
    G. Delbarre, B. Delbarre, and F. Calinon, Increase of amino acids in gerbil after ischemia, FASEB J. 4:A1128–5008 (1990).Google Scholar
  16. 16.
    J.W. Phillis and C. Clough-Helfman, Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN), Neurosci. Lett. 116:315 (1990).PubMedCrossRefGoogle Scholar
  17. 17.
    J.W. Phillis and C. Clough-Helfman, Free radicals and ischaemic brain injury: Protection by the spin trap agent PBN, Med. Sci. Res 18:403 (1990).Google Scholar
  18. 18.
    C. Clough-Helfman and J.W. Phillis, The free radical trapping agent N-tert-butyl-α-phenylnitrone (PBN) attenuates cerebral ischaemic injury in gerbils, Free Radic. Res. Commun. 15:177 (1991).PubMedCrossRefGoogle Scholar
  19. 19.
    J.M. Carney, P.E. Starke-Reed, C.N. Oliver, R.W. Landrum, M.S. Chen, J.F. Wu, and R.A. Floyd, Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spacial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone, Proc. Natl. Acad. Sci. USA 88: 3633 (1991).PubMedCrossRefGoogle Scholar
  20. 20.
    R.A. Floyd and J.M. Carney, Nitrone radicals traps (NRTs) protect in experimental neurodegenerative diseases, in: “Neuroprotective Approaches to the Treatment of Parkinson’s Disease and Other Neurodegenerative Disorders,” C. A. Chapman, C.W. Olanow, P. Jenner, and M. Youssim, eds., Academic Press Limited, London (1993).Google Scholar
  21. 21.
    G. Chen, T.M. Bray, E.G. Janzen, and P.B. McCay, Excretion, metabolism and tissue distribution of a spin trapping agent, α-phenyl-N-tert-butyl-nitrone (PBN) in rats, Free Radic. Res. Commun. 9:317 (1990).PubMedCrossRefGoogle Scholar
  22. 22.
    X. Cao and J.W. Phillis, α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia, Brain Res. 644:267 (1994).PubMedCrossRefGoogle Scholar
  23. 23.
    Q. Zhao, K. Pahlmark, M.L. Smith, and B.K. Siesjo, Delayed treatment with the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats, Acta. Physiol Scand. 152:349 (1994).PubMedCrossRefGoogle Scholar
  24. 24.
    S. Sen, H. Goldman, M. Morehead, S. Murphy, and J.W. Phillis, α-Phenyl-tert-butyl-nitrone inhibits free radical release in brain concussion, Free Radic. Biol. Med. 16:685 (1994).PubMedCrossRefGoogle Scholar
  25. 25.
    M. Lafon-Cazal, S. Pietri, M. Culcasi, and J. Bockaert, NMDA-dependent Superoxide production and neurotoxicity, Nature 364:535 (1993).PubMedCrossRefGoogle Scholar
  26. 26.
    M.F. Beal, Mechanisms of excitotoxicity in neurologic diseases, FASEB J. 6:3338 (1992).PubMedGoogle Scholar
  27. 27.
    J.B. Schulz, D.R. Henshaw, D. Siwek, B.G. Jenkins, R.J. Ferrante, P.B. Cipolloni, N.W. Kowall, B.R. Rosen, and M.F. Beal, Involvement of free radicals in excitotoxicity in vivo, J. Neuropathol. 64:2239 (1995).Google Scholar
  28. 28.
    P.K. Wong, J.L. Poyer, C.M. DuBose, and R.A. Floyd, Hydralazine-dependent carbon dioxide free radical formation by metabolizing mitochondria, J. Biol. Chem. 263:11296 (1988).PubMedGoogle Scholar
  29. 29.
    P.K. Wong and R.A. Floyd, Unpublished observations (1995).Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Robert A. Floyd
    • 1
  1. 1.Oklahoma Medical Research FoundationOklahoma CityUSA

Personalised recommendations